Sylvester treats first patients with novel MRI-guided radiation therapy
As the first cancer center in South Florida, Sylvester Comprehensive Cancer Center, part of UHealth – the University of Miami Health System, has begun treating patients with a novel form of MRI-guided radiation therapy called the MRIdian System.
MRIdian integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of tumors while radiation is delivered. MRIdian is the only system that can provide continuous soft-tissue imaging during radiation treatment. This means that, for the first time, doctors are able to see the tumor they are treating continuously, enabling personalized and truly adaptive radiation therapy.
“The ability to view the tumor and normal tissues in real-time using MRI guidance is a huge advance in radiation therapy, which we expect to benefit patients through improvements in tumor control and reduced toxicity,” said Alan Pollack, M.D., Ph.D., Radiation Oncology Chair at Sylvester. “We’re proud to offer this advanced cancer treatment to patients within Florida and beyond.”
The first two cancer patients were treated using the system over the past two weeks. Sylvester is currently ramping up the use of MRIdian and doctors are excited to be able to provide this world-class technology to Sylvester patients.
“Sylvester Comprehensive Cancer Center at the University of Miami is renowned for its research and cutting-edge treatments,” said Chris A. Raanes, president and CEO of ViewRay Incorporated, the company that developed MRIdian. “We are delighted that they see how MRIdian can help cancer patients.”